NXL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.00%

Insider Buying (Last 12 Months): $4,765.00

Insider Selling (Last 12 Months): $0.00

Nexalin Technology Insider Trading History Chart

Nexalin Technology Share Price & Price History

^$2.63

▼ -0.43 (-14.05%)

As of 12/20/2024 06:45 PM ET

Days: 30 | 90 | 365

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Nexalin Technology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/28/2024	David Owens	Insider	Buy	500	$2.19	$1,095.00	148,293
6/28/2024	David Owens	Insider	Buy	1,000	$1.75	$1,750.00	146,793
6/10/2024	David Owens	Insider	Buy	3,000	$0.64	$1,920.00	144,174
9/28/2022	Marilyn Elson	CFO	Buy	9,500	$1.12	$10,640.00	835,244

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

SEC Filings (Institutional Ownership Changes) for Nexalin Technology (NASDAQ:NXL)

0.65% of Nexalin Technology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Nexalin Technology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company	Details
8/15/2024	CVI Holdings LLC	55,462	$94K	0.1%	N/A	0.524%

Data available starting January 2016

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Today's Range

Now: $2.63

$2.55

$3.06

50 Day Range

MA: $3.19

$0.79

$4.36

52 Week Range

Now: $2.63

$0.25

$4.49

Volume

895,386 shs

Average Volume

1,382,652 shs

Market Capitalization

$33.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.78

Who are the company insiders with the largest holdings of Nexalin Technology?: Nexalin Technology's top insider investors include:
David Owens (Insider)
Learn More about top insider investors at Nexalin Technology.